Centers For Medicare And Medicaid Services

Coming to America? Novartis subsidiary launches first biosimilar product in the US

Update - Wholesale cost of Zarxio will be 15% less than Amgen's Neupogen

Biosimilars land in the US as Sandoz launches Zarxio

By Dan Stanton

Sandoz has launched Zarxio, the first biosimilar in the US, despite a last ditch effort to block the copycat version of Neupogen by Amgen.

US CMS releases new info around biosimilar pricing, uptake

US CMS releases new info around biosimilar pricing, uptake

By Zachary Brennan

With the release of four different documents around the pricing and use of biosimilars this week, the US CMS (Centers for Medicare and Medicaid Services) is making clear it will fully encourage states to call on prescribers to use cost-effective biosimilars...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers